Skip to main content

7 Worst Stocks in the Nasdaq on Tuesday: Moderna Slides

The worst-performing stocks in the Nasdaq on Tuesday included Moderna, Pinduoduo Inc ADR, and Tesla among others.

Stocks were lower Tuesday as a new strain of the coronavirus in the U.K. has Wall Street worried it could spread and lead to fresh restrictions on businesses.

The Dow fell 114 points, or 0.38%, to 30,101, the S&P 500 fell 0.15% and the Nasdaq was rising 0.2%. The Nasdaq set an intraday record high during Tuesday's session.

Here are the worst stocks in the Nasdaq on Tuesday by their performance in percentage change at the close of trading on Dec. 22.

1. Moderna Inc | Decreased -8.98%

Moderna’s  (MRNA) - Get Moderna, Inc. Report coronavirus vaccine candidate won approval from an FDA advisory committee late Thursday, paving the way for the second vaccine candidate to combat the Covid-19 pandemic to win full FDA approval.

The committee voted 20-0 with one abstention to recommend that the FDA grant Moderna’s emergency use authorization.

2. Pinduoduo Inc | Decreased -5.34%

In November, shares of Pinduoduo  (PDD) - Get Pinduoduo Inc. Report jumped after the Chinese e-commerce platform reported a surprise adjusted profit and a jump in revenue.

The Shanghai company reported a third-quarter net loss of $115.6 million. Adjusted profit was 0.33 yuan per American depositary share, topping analyst estimates of a loss of 1.14 yuan a share. 

Scroll to Continue

TheStreet Recommends

3. Lululemon Athletica| Decreased -3.57%

Earlier this month, Lululemon  (LULU) - Get Lululemon Athletica Inc Report shares were falling 0.97% in pre-market trading to $365.50 despite the upscale athleisure retailer reporting third-quarter results that topped analyst estimates for the period. 

4. Walgreens Boots Alliance | Decreased -3.44%

Drugstore chain Walgreens  (WBA) - Get Walgreens Boots Alliance Inc Report will provide Pfizer's PFE coronavirus vaccine to residents of nursing homes and assisted living facilities starting next week, despite scheduling glitches cited by some nursing home operators.

5. Amgen Inc | Decreased -2.78%

In October, Amgen  (AMGN) - Get Amgen Inc. Report shares were little changed after the biotechnology titan reported stronger-than-expected third-quarter results.

Revenue totaled $6.423 billion for the quarter, up 12% from $5.737 billion a year earlier. The FactSet analyst consensus called for $6.38 billion in the latest quarter.

6. Facebook Inc | Decreased -2.09%

Alphabet's Google  (GOOGL) - Get Alphabet Inc. Class A Report and Facebook  (FB) - Get Meta Platforms Inc. Class A Report agreed to "cooperate and assist one another" if they ever faced an investigation into their pact to work together in online advertising, according to an unredacted version of a lawsuit filed by 10 states against Google last week.

7. Tesla Inc | Decreased -1.46%

Tesla Inc.  (TSLA) - Get Tesla Inc Report shares slumped lower heading into its S&P 500 debut Monday following a record year for the clean energy carmaker that has added more than half a trillion dollars to its market value.

Tesla entered the S&P 500 as the benchmark's fifth-biggest stock, with a weighting of 1.69% and a market value of around $650 billion following Friday's record-high close of $695.00 per share.

All stock prices and activity referenced are pulled from